Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report

Baltahi, E; Altundag, MK; Onat, DA; Abbasoglu, O; Ozisik, Y; Guler, N; Atahan, L; Berberoglu, U; Altinok, M; Baran, I; Celik, İSMAİL; Tekuzman, G

doi:10.1177/030089160208800608

Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report

Baltahi E., Altundag M., Onat D., Abbasoglu O., Ozisik Y., Guler N., ...Daha Fazla

TUMORI J, cilt.88, sa.6, ss.474-477, 2002 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 88 Sayı: 6
Basım Tarihi: 2002
Doi Numarası: 10.1177/030089160208800608
Dergi Adı: TUMORI J
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.474-477
Hacettepe Üniversitesi Adresli: Evet

Özet

Aims and background: Sixty-three patients with local-regionally advanced breast cancer were treated with neoadjuvant chemotherapy consisting of docetaxel (Taxotere), epirubicin, and 5-fluorouracil (TEF).